Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK721588Aexternal-prioritypatent/DK721588D0/da
Priority claimed from DK477789Aexternal-prioritypatent/DK477789D0/da
Priority claimed from PCT/DK1989/000296external-prioritypatent/WO1990007522A1/en
Application filed by Novo Nordisk AsfiledCriticalNovo Nordisk As
Priority to DK119391ApriorityCriticalpatent/DK166730C/da
Publication of DK119391D0publicationCriticalpatent/DK119391D0/da
Publication of DK119391ApublicationCriticalpatent/DK119391A/da
Publication of DK166730BpublicationCriticalpatent/DK166730B/da
Application grantedgrantedCritical
Publication of DK166730CpublicationCriticalpatent/DK166730C/da
DK119391A1988-12-231991-06-20Humaninsulinanaloger og deres farmaceutisk tolerable salte samt farmaceutiske praeparater indeholdende disse
DK166730C
(da)
Tetrahydronaphthalen- og indanderivater og farmaceutiske midler indeholdende disse samt anvendelse af forbindelserne til fremstilling af et laegemiddel
Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne